HGHIX Mutual Fund

NAV$41.10

Fund Essentials - as of Oct 31, 2025

Net Assets
$205M
Expense Ratio
1.02%
Dividend Yield (Current)
3.24%
Holdings
77
Inception Date
Aug 31, 2006
Fund Family
Hartford Funds
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+0.95%
1 Year+16.25%
3 Year+9.90%
5 Year+6.36%
10 Year+14.09%

Asset Allocation

Stocks: 99.35%
Bonds: 0.33%
Cash: 0.32%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co12.98%
UNHUnitedHealth Group Incorporated5.84%
ABBVAbbvie Inc4.69%
JNJJohnson & Johnson4.48%
MRKMerck & Company Inc4.22%
Top 10 Concentration: 48.49%Report Date: Oct 31, 2025
Download all 77 holdings for HGHIX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.24%
Frequency
Annually
Latest Distribution
$4.37
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

HGHIX Mutual Fund Overview

HGHIX Mutual Fund (The Hartford Healthcare Fund Class I) is managed by Hartford Funds with $204.9M in net assets. HGHIX expense ratio is 1.02%, holding 77 positions across sectors including Health Care, Unknown, Financials. Inception date: 2006-08-31.

HGHIX performance shows a YTD return of 0.95%. The 1-year return is 16.25% and the 5-year return is 6.36%. HGHIX dividend yield stands at 3.24%, paid annually.

HGHIX top holdings include Eli Lilly & Co (13.0%), UnitedHealth Group Incorporated (5.8%), Abbvie Inc (4.7%), Johnson & Johnson (4.5%), Merck & Company Inc (4.2%). View all HGHIX holdings, sector breakdown, or dividend history.

HGHIX can be compared against other funds using the overlap calculator or side-by-side comparison tool. HGHIX alternatives are available via the screener, along with tax-loss harvesting opportunities.